Literature DB >> 21657943

Familial hypercholesterolemia: epidemiology, Neolithic origins and modern geographic distribution.

Khemanganee E Liyanage1, John R Burnett, Amanda J Hooper, Frank M van Bockxmeer.   

Abstract

The elucidation of the molecular basis of familial hypercholesterolemia (FH) by Brown and Goldstein about three decades ago provided the most convincing evidence for a causative relationship between a high plasma level of low-density lipoprotein (LDL) cholesterol and the conditions of atherosclerosis and premature atherosclerotic cardiovascular disease. Today, with a prevalence of about one in 500 individuals, FH remains the most common monogenic disorder of lipoprotein metabolism, and is mainly due to mutations in the LDL receptor (LDLR) gene that lead to the plasma accumulation of cholesterol ester-laden LDL particles. Another form of autosomal dominant hypercholesterolemia, familial defective apolipoprotein B-100, a genocopy of FH caused by defects in the APOB gene that lead to decreased clearance of LDL, is now established as a significant cause of coronary heart disease. Yet another form, due to mutations in the proprotein convertase subtilisin/kexin type 9 (PCSK9) gene, has been recently identified that similarly causes decreased clearance of LDL by novel mechanisms also involving the hepatic LDLR endocytotic pathway. Recent advances in molecular genotyping technology have yielded a staggering amount of detail about human genetic diversity at the single nucleotide level in both private and public databases including the International HapMap Consortium. This, as well as the availability of ancient human DNA from burial sites and the development of new statistical methods, now provide an unprecedented capacity to study human demography and the ability to examine the genealogical ties between ancient and modern people. The aim of this article is to review the epidemiology of FH, and to attempt to draw inferences from our knowledge at a DNA level of inherited hypercholesterolemia of contemporary people that may contribute to the understanding of human population history and adaptation that resulted in the massive demographic expansion following the adoption of agriculture in the Neolithic period.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21657943     DOI: 10.3109/10408363.2011.565585

Source DB:  PubMed          Journal:  Crit Rev Clin Lab Sci        ISSN: 1040-8363            Impact factor:   6.250


  18 in total

Review 1.  Clinical utility gene card for: hyperlipoproteinemia, TYPE II.

Authors:  Ursula Kassner; Marion Wühle-Demuth; Isabelle Missala; Steve E Humphries; Elisabeth Steinhagen-Thiessen; Ilja Demuth
Journal:  Eur J Hum Genet       Date:  2013-11-20       Impact factor: 4.246

2.  Loss of plasma proprotein convertase subtilisin/kexin 9 (PCSK9) after lipoprotein apheresis.

Authors:  Hagai Tavori; Ilaria Giunzioni; MacRae F Linton; Sergio Fazio
Journal:  Circ Res       Date:  2013-10-11       Impact factor: 17.367

3.  Reduced contribution of endothelin to the regulation of systemic and pulmonary vascular tone in severe familial hypercholesterolaemia.

Authors:  Shawn B Bender; Vincent J de Beer; Darla L Tharp; Elza D van Deel; Douglas K Bowles; Dirk J Duncker; M Harold Laughlin; Daphne Merkus
Journal:  J Physiol       Date:  2014-01-13       Impact factor: 5.182

Review 4.  Criteria for Diagnosis of Familial Hypercholesterolemia: A Comprehensive Analysis of the Different Guidelines, Appraising their Suitability in the Omani Arab Population.

Authors:  Khalid Al-Rasadi; Khalid Al-Waili; Hilal Ali Al-Sabti; Ali Al-Hinai; Khamis Al-Hashmi; Ibrahim Al-Zakwani; Yajnavalka Banerjee
Journal:  Oman Med J       Date:  2014-03

5.  Differential impact of severe familial hypercholesterolemia on regional skeletal muscle and organ blood flows during exercise: Effects of PDE5 inhibition.

Authors:  Christian G Aragonez; Vincent J de Beer; Darla L Tharp; Douglas K Bowles; M Harold Laughlin; Daphne Merkus; Dirk J Duncker; Shawn B Bender
Journal:  Microcirculation       Date:  2019-03-26       Impact factor: 2.628

6.  Genealogical analysis as a new approach for the investigation of drug intolerance heritability.

Authors:  Marc Tremblay; Tarek Bouhali; Daniel Gaudet; Diane Brisson
Journal:  Eur J Hum Genet       Date:  2013-11-27       Impact factor: 4.246

7.  Severe familial hypercholesterolemia impairs the regulation of coronary blood flow and oxygen supply during exercise.

Authors:  Shawn B Bender; Vincent J de Beer; Darla L Tharp; Douglas K Bowles; M Harold Laughlin; Daphne Merkus; Dirk J Duncker
Journal:  Basic Res Cardiol       Date:  2016-09-13       Impact factor: 17.165

Review 8.  Novel Therapies for Familial Hypercholesterolemia.

Authors:  Justin Parizo; Ashish Sarraju; Joshua W Knowles
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-11

Review 9.  Dietary fats and health: dietary recommendations in the context of scientific evidence.

Authors:  Glen D Lawrence
Journal:  Adv Nutr       Date:  2013-05-01       Impact factor: 8.701

Review 10.  Genetic and microbiome influence on lipid metabolism and dyslipidemia.

Authors:  Maria Luisa Matey-Hernandez; Frances M K Williams; Tilly Potter; Ana M Valdes; Tim D Spector; Cristina Menni
Journal:  Physiol Genomics       Date:  2017-12-20       Impact factor: 3.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.